Physical impairments, sensory disturbance, and functional ability in a cancer patient with and without chemotherapy-induced peripheral neuropathy symptoms
Sign Up to like & getrecommendations! Published in 2022 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-022-06927-5
Abstract: The present study examined the objective and patient-reported measures of physical impairments, sensory disturbance, and functional ability between cancer patients with and without chemotherapy-induced peripheral neuropathy (CIPN) symptoms. Forty-one cancer survivors exposed to neurotoxic chemotherapies… read more here.
Keywords: cancer; patient; test; cipn symptoms ... See more keywords
Impact of chemotherapy-induced peripheral neuropathy permanence on patients' preference to discontinue chemotherapy.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.12046
Abstract: 12046 Background: Chemotherapy-induced peripheral neuropathy (CIPN) diminishes patients’ functional ability and quality of life; approximately 40% of patients experience CIPN symptoms 3 years after treatment. Due to the absence of effective CIPN treatments, ASCO guidelines… read more here.
Keywords: treatment; chemotherapy; cipn symptoms; discontinue chemotherapy ... See more keywords